Robert F. Kennedy Jr., serving as Secretary of Health and Human Services, faced consecutive congressional hearings this week in which lawmakers questioned him on vaccine policy, cuts to the Centers for Disease Control and Prevention, and proposed changes to Medicaid funding. The hearings represented one of the most direct instances of legislative oversight Kennedy has encountered since taking office.

Senate Health Committee Chairman Bill Cassidy, a physician and Louisiana Republican, led one of the sessions and pressed Kennedy on the scientific basis for several health agency decisions made under his tenure. Kennedy has previously expressed skepticism about vaccine safety and the independence of federal health research, positions that have generated sustained controversy in the scientific and medical communities.

Questions during the hearings covered a broad range of topics, including proposed reductions to CDC staffing and programs, the administration's approach to childhood vaccination recommendations, and the future of Medicaid amid budget negotiations. Kennedy defended the administration's direction, arguing that greater scrutiny of existing health guidance is warranted.

The hearings came as the Trump administration continues to pursue significant restructuring of federal health agencies, including personnel changes at the FDA and CDC. Critics, including many public health experts, have warned that the changes could undermine longstanding disease prevention infrastructure. Supporters of Kennedy's approach contend that the agencies had grown insulated from accountability and external review.

Separately, Kennedy has maintained a public media presence, including podcast appearances, that has kept his views on vaccines and federal health oversight in the national conversation. The dual pressure of congressional oversight and public scrutiny signals that Kennedy's stewardship of the nation's health agencies will remain a focal point of political debate in the months ahead.